Collaborations

Alana Welm Lab at HCI and Sunil Sharma Lab at TGen

Design, synthesis and biological evaluation of phosphonate containing clinical stage agents such as BMS-777607, LY2801653, and internally discovered novel RON kinase inhibitors

Michael Deininger/Thomas O’Hare Lab at HCI

Early discovery and development of novel SIRT5 selective agents for AML cancers

Bradley Cairns Lab

Early discovery and development of novel SWI/SNF complex targeting SMARCA2 and SMARCA4 inhibitors

Martin McMahon Lab

Early discovery and development of novel KRAS effector targeting small molecules for NSCLC and other solid tumors

Chandrasekharan Lab

Disrupting WDR5/MLL-1 PPIs: Inhibition of cancer-promoting activity of the MLL-1 protein by targeting WDR5

Collaborations with College of Pharmacy Investigators

  • Darrell R. Davis, PhD, Chair, Professor of Medicinal Chemistry and of Biochemistry
  • Randall T. Peterson, PhD, Dean, College of Pharmacy
  • Kuberan Balagurunathan, PhD, Professor of Medicinal Chemistry
vankayalapati,-hariprasad.jpg

Hariprasad Vankayalapati, MPharm, PhD
Principal Investigator
hari@hci.utah.edu
801-213-8424

Affiliations

  • Center for Investigational Therapeutics (CIT) at Huntsman Cancer Institute
  • College of Pharmacy